(Q43817916)

27 November 2017

title

Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide (English)

1 reference

27 November 2017

Biological activity ofBurkholderia (Pseudomonas) cepacialipopolysaccharide (English)

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

5 July 2024

0 references

D. Shaw

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7640678

5 July 2024

I. R. Poxton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7640678

5 July 2024

J. R. Govan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7640678

5 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7640678

5 July 2024

publication date

1 April 1995

1 reference

FEMS Immunology and Medical Microbiology

27 November 2017

published in

1 reference

27 November 2017

volume

11

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

99-106

1 reference

Microbiology of lung infection in cystic fibrosis

27 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Antibiotic resistance of Pseudomonas species

5 July 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia

5 July 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

5 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

5 July 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

The chemical structure of bacterial endotoxin in relation to bioactivity

5 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis

5 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.

5 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.

5 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

5 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels

5 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

5 July 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Detection of 2-keto-3-deoxyoctonate in endotoxins isolated from six reference strains of the Bacteroides fragilis group

5 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Protein measurement with the Folin phenol reagent

5 July 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Colorimetric Method for Determination of Sugars and Related Substances

5 July 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis

5 July 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Structures of the O-specific polymers from the lipopolysaccharides of the reference strains for Pseudomonas cepacia serogroups O3 and O5.

5 July 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Structure of the putative O antigen containing 2-amino-2-deoxy-l-glucose in the reference strain for Pseudomonas cepacia serogroup O1

5 July 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance

5 July 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Pyrrolnitrin Production by Biological Control Agent Pseudomonas cepacia B37w in Culture and in Colonized Wounds of Potatoes

5 July 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

An Antimicrobial Substance Produced by Pseudomonas cepacia B5 against the Bacterial Wilt Disease Pathogen, Pseudomonas solanacearum

5 July 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Phenotypic comparison between rhizosphere and clinical isolates of Burkholderia cepacia

5 July 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Validation of the Publication of New Names and New Combinations Previously Effectively Published Outside the IJSB: List No. 45

5 July 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Isolation of Atypical Lipopolysaccharides from Purified Cell Walls of Pseudomonas cepacia

5 July 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

3-deoxy-D-manno-2-octulosonic acid in the lipopolysaccharide of various strains of Pseudomonas cepacia

5 July 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Isolation and characterization of the outer and cytoplasmic membranes of Pseudomonas cepacia

5 July 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens

5 July 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1995.TB00095.X

5 July 2024

Identifiers

10.1016/0928-8244(95)00012-V

1 reference

27 November 2017

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7640678

5 July 2024

1 reference